ADVERTISEMENT
President Donald Trump signed an executive order Saturday that he said “directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs.” A primary objective of the order is to speed treatment for veterans.
The president said the executive order would implement “historic reforms to dramatically accelerate access to new medical research and treatments based on psychedelic drugs.” Citing the elevated veteran suicide rate, the president added: “In many cases, these experimental treatments have shown life-changing potential for those suffering from severe mental illness and depression, including our cherished veterans.”
ADVERTISEMENT
ADVERTISEMENT